Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters











Publication year range
1.
Microb Pathog ; 144: 104127, 2020 Jul.
Article in English | MEDLINE | ID: mdl-32169485

ABSTRACT

Despite the main strategy to overcome bacterial resistance has focused on the development of more potent antimicrobial agents, the evolutionary pressure caused by such drugs makes this strategy limited. Molecules that interfere with virulence factors appear as a promising alternative though, as they cause reduced selective pressure. As a matter of fact, staphyloxanthin biosynthesis inhibition (STXBI) has been pursued as promising strategy to reduce S. aureus virulence. Herein, we report the inhibitory profile of 27 tetrangomycin derivatives over staphyloxanthin production. The experimental result showed that naphthoquinone dehydro-α-lapachone (25 - EC50 = 57.29 ± 1.15 µM) and 2-Isopropylnaphtho[2,3-b]furan-4,9-dione (26 EC50 = 82.10 ± 1.09 µM) are the most potent compounds and suggest that hydrogen acceptor groups and lipophilic moieties decorating the naphthoquinone ring are crucial for STXBI. In addition, we present an in situ analysis, through RAMAN spectroscopy, that is inexpensive and might be employed to probe the mechanism of action of staphyloxanthin biosynthesis inhibitors. Therefore, our molecular simplification strategies afforded promising lead compounds for the development of drugs that modulate S. aureus staphyloxanthin biosynthesis.


Subject(s)
Anti-Bacterial Agents/pharmacology , Naphthoquinones/pharmacology , Staphylococcus aureus/metabolism , Xanthophylls/metabolism , Benz(a)Anthracenes/chemistry , Benz(a)Anthracenes/pharmacology , Drug Resistance, Multiple, Bacterial , Naphthalenes/chemistry , Naphthalenes/pharmacology , Naphthoquinones/chemistry , Staphylococcus aureus/drug effects , Structure-Activity Relationship , Virulence Factors/antagonists & inhibitors , Virulence Factors/biosynthesis
2.
Clin Exp Immunol ; 177(1): 320-32, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24666437

ABSTRACT

Epstein-Barr virus (EBV) is present in 95% of the world's adult population. The immune response participates in immune vigilance and persistent infection control, and this condition is maintained by both a good quality (functionality) and quantity of specific T cells throughout life. In the present study, we evaluated EBV-specific CD4(+) and CD8(+) T lymphocyte responses in seropositive healthy individuals younger and older than 50 years of age. The assessment comprised the frequency, phenotype, functionality and clonotypic distribution of T lymphocytes. We found that in both age groups a similar EBV-specific T cell response was found, with overlapping numbers of tumour necrosis factor (TNF)-α(+) T lymphocytes (CD4(+) and CD8(+)) within the memory and effector cell compartments, in addition to monofunctional and multi-functional T cells producing interleukin (IL)-2 and/or interferon (IFN)-γ. However, individuals aged more than 50 years showed significantly higher frequencies of IL-2-producing CD4(+) T lymphocytes in association with greater production of soluble IFN-γ, TNF-α and IL-6 than subjects younger than 50 years. A polyclonal T cell receptor (TCR)-variable beta region (Vß) repertoire exists in both age groups under basal conditions and in response to EBV; the major TCR families found in TNF-α(+) /CD4(+) T lymphocytes were Vß1, Vß2, Vß17 and Vß22 in both age groups, and the major TCR family in TNF-α(+) /CD8(+) T cells was Vß13·1 for individuals younger than 50 years and Vß9 for individuals aged more than 50 years. Our findings suggest that the EBV-specific T cell response (using a polyclonal stimulation model) is distributed throughout several T cell differentiation compartments in an age-independent manner and includes both monofunctional and multi-functional T lymphocytes.


Subject(s)
CD4-Positive T-Lymphocytes/immunology , CD8-Positive T-Lymphocytes/immunology , Epstein-Barr Virus Infections/immunology , Herpesvirus 4, Human/immunology , T-Lymphocyte Subsets/immunology , Adult , Age Factors , Aged , Aged, 80 and over , Antibodies, Viral/blood , Antigens, Viral/immunology , Asymptomatic Diseases , CD4-Positive T-Lymphocytes/virology , CD8-Positive T-Lymphocytes/virology , Clone Cells , Colombia , Epstein-Barr Virus Infections/epidemiology , Female , Humans , Immunologic Memory , Immunophenotyping , Interferon-gamma/metabolism , Interleukin-2/metabolism , Male , Middle Aged , Receptors, Antigen, T-Cell, alpha-beta/genetics , T-Lymphocyte Subsets/virology , Tumor Necrosis Factor-alpha/metabolism , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL